Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism

Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial

(2014) Katsuyuki Ando et al.   Lancet Diabetes & Endocrinology

Resistant hypertension and target organ damage

(2013) Maria Lorenza Muiesan et al.   HYPERTENSION RESEARCH

Predictors of Decreasing Glomerular Filtration Rate and Prevalence of Chronic Kidney Disease After Treatment of Primary Aldosteronism: Renal Outcome of 213 Cases

(2013) Yoshitsugu Iwakura et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways

(2012) Ana M. Briones et al.   HYPERTENSION

Mineralocorticoid receptor antagonists: their use and differentiation in Japan

(2012) Atsuhisa Sato   HYPERTENSION RESEARCH

Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension

(2012) GianLuca Colussi et al.   JOURNAL OF HYPERTENSION

Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension

(2012) Pieter M. Jansen et al.   JOURNAL OF HYPERTENSION

Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009-

(2011) Tetsuo Nishikawa et al.   ENDOCRINE JOURNAL

Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats

(2011) Taishi Nakamura et al.   HYPERTENSION RESEARCH

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

(2011) Hari K Parthasarathy et al.   JOURNAL OF HYPERTENSION

A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome

(2011) Wojciech Kosmala et al.   JACC-Cardiovascular Imaging

Treatment of primary aldosteronism

(2010) Marcus Quinkler et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria

(2010) Masanori Abe et al.   HYPERTENSION RESEARCH

Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects

(2010) Yuji Ito et al.   HYPERTENSION RESEARCH

Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice

(2009) Ayumu Hirata et al.   CARDIOVASCULAR RESEARCH

Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R

(2009) Tsuyoshi Isaka et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas

(2008) A. Karagiannis et al.   ENDOCRINE-RELATED CANCER

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism

(2008) Asterios Karagiannis et al.   EXPERT OPINION ON PHARMACOTHERAPY